ArticleBMJ open2024

Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial.

Jordi A Matias-Guiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.